Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.
Join the community
Most Read
1. Raffles Hospital and AIA Singapore ink MoU to boost healthcare access 2. Australia to fast-track registration for internationally qualified nurses 3. Healthcare stakeholders told to push rule changes in Asia 4. Singapore to raise 37,000 public healthcare workers’ salaries by mid-2025 5. India’s Artemis Hospital unveils new mobile health clinic for rural areasResource Center
Awards
Apr
10
Events
Event News
Co-Written / Partner
KPMG’s Peter Liddell advocates resilient healthcare solutions
He discussed the pressing challenges and transformative solutions shaping the future of healthcare in the Asia Pacific.